regional medical center: World Drug Repositioning Congress 2012, 11-13 September, London, UK

Selasa, 15 Mei 2012

World Drug Repositioning Congress 2012, 11-13 September, London, UK

World Drug Repositioning Congress 2012, 11-13 September, London, UK

Main Category: Conferences
Article Date: 15 May 2012 - 8:00 PDT

email to a friend Â

printer friendly Â

opinions Â <!--

rate article

Patient / Public: not yet rated

Healthcare Prof: not yet rated

Drug development strategies for indication expansion and lifecycle extension
11 - 13 September 2012, Jumeirah Carlton Tower, London, UK

As the cost and time of drug development persistently increases, drug repositioning is becoming an increasingly important strategy for large pharma and small biotech alike to successfully innovate in a more cost-effective environment.

The 2012 World Drug Repositioning Congress is Europe's only commercially orientated conference that provides key technical and strategic solutions to challenges faced when adopting drug repositioning into your RD efforts.

10 Reasons to attend

Discover how systematic drug repositioning is fast becoming a powerful tool to identify and commercialise new uses for your existing compounds
Hear how Celgene innovated and obtained approvals for Thalidomide and its successor compounds
Understand how GSK, Eli Lilly, Sanofi, Merck Serono,Boehringer-Ingelheim and more are looking to repurpose their vast archives of compounds
Learn about a novel project-based approach to financing your drug repositioning research
Discover successful strategies to repurpose both failed and market approved compounds and maximise their commercial value
Hear how to harness IP law to extend a product's life cycle and repurpose a compound successfully with market exclusivity
Learn how repositioning known compounds can lead to cheaper and quicker drug development
Discover how to curate and integrate vast amounts of available data to positively impact drug repositioning timelines
Learn how the European PONTE project is driving efficient patient recruitment for innovative clinical trials of existing drugs to other indications Hear how drug repositioning is a gateway for coordinated collaboration to research and treat neglected and orphan diseases

Visit our website for full list of speakers and programe: http://www.terrapinn.com/conference/drug-repositioning

Download the brochure for more information.

To book your place contact: Marcia Ardila on email: marcia.ardila@terrapinn.com or register your place online here.

Additional

References

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

APA

Please note: If no author information is provided, the source is cited instead.

Add Your Opinion On This Article

'World Drug Repositioning Congress 2012, 11-13 September, London, UK'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

regional medical center

Selasa, 15 Mei 2012

World Drug Repositioning Congress 2012, 11-13 September, London, UK

Add Your Opinion On This Article

Tidak ada komentar:

Posting Komentar